Thema: KI-Impfstoff

KI-Impfstoff, Cambridge

Erfolgreiche Phase-1-Studie fĂŒr KI-entwickelten Impfstoff pEVAC-PS. Sicherheit bestĂ€tigt Wirksamkeit ...

A close-up shot of a needle-free vaccine delivery system on a human arm, with glowing screens displaying DNA sequences in a futuristic lab. - Foto: ĂŒber boerse-global.de
A close-up shot of a needle-free vaccine delivery system on a human arm, with glowing screens displaying DNA sequences in a futuristic lab. - Foto: ĂŒber boerse-global.de

KI-Impfstoff: Cambridge testet erstmals KI-designtes Antigen am Menschen

boerse-global.de, 10.06.26 11:33 Uhr
A glowing neural network overlaying a virus particle, with DNA strands and data points, symbolizing AI-designed vaccines. - Foto: ĂŒber boerse-global.de
A glowing neural network overlaying a virus particle, with DNA strands and data points, symbolizing AI-designed vaccines. - Foto: ĂŒber boerse-global.de
A glowing, abstract neural network merges with stylized coronavirus particles and DNA strands, symbolizing AI-designed vaccine technology. - Foto: ĂŒber boerse-global.de
A glowing, abstract neural network merges with stylized coronavirus particles and DNA strands, symbolizing AI-designed vaccine technology. - Foto: ĂŒber boerse-global.de